Apnimed was founded in 2017 by Lawrence G. Miller and Luigi Taranto Montemurro. Apnimed has not officially endorsed a plan to participate in an IPO.

Apnimed is a pharmaceutical company developing oral pharmacologic treatments for obstructive sleep apnea and other related disorders. Per Forge data, Apnimed has raised a total of $207.8 million in funding over 5 rounds. Their latest funding was raised on Dec 23, 2022, from a Series C round. Key investors include Sectoral Asset Management, Morningside Venture Partners, and Alpha Wave Ventures.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Apnimed, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Apnimed

Forge green plus iconForge green minus icon

What is Apnimed's IPO price?

The IPO price for Apnimed will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Apnimed?

Apnimed is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Apnimed shares pre-IPO?

If you own Apnimed pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Apnimed a publicly traded company?

Apnimed is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Apnimed's funding to date?

Apnimed has raised $208.02MM to date.
Forge green plus iconForge green minus icon

When was Apnimed founded?

Apnimed was founded in 2017.

Who are Apnimed's major investors?

Tao Capital Partners
Morningside Group
Alpha Wave Global
Sectoral Asset Management
Seligman Technology Group

Apnimed Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
12/22/2022 Series C-3 $79.75MM raised $XXX.XX $XXX.XX
5/4/2022 Series C-1 and C-2 $62.5MM raised $XXX.XX $XXX.XX
3/25/2021 Series B $25MM raised $XXX.XX $XXX.XX
3/31/2020 Series A-2 $15MM raised $XXX.XX $XXX.XX
6/25/2018 Series A $25.77MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.